Merck Serono Cancer Pill 'Offers MS Benefits', Queen Mary School of Medicine Study

Published: Apr 30, 2009

Bookmark and Share

Queen Mary -- A new drug for multiple sclerosis can dramatically reduce the chances of a relapse or a deterioration of the condition, according to a new study from researchers at Queen Mary, University of London.

Back to news